The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
Eur Heart J
; 41(46): 4389-4390, 2020 Dec 07.
Article
in English
| MEDLINE | ID: covidwho-1059171
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
Language:
English
Journal:
Eur Heart J
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS